[en] BACKGROUND: Many patient-reported outcomes (PROs) have been developed for inflammatory bowel disease (IBD) without recommendations for clinical use. PROs differ from physician-reported disease activity indices; they assess patients' perceptions of their symptoms, functional status, mental health, and quality of life, among other areas. We sought to investigate the current global use and barriers to using PROs in clinical practice for IBD. METHODS: A cross-sectional survey was performed. An electronic questionnaire was sent to an international group of providers who care for patients with IBD. RESULTS: There were 194 respondents, including adult/pediatric gastroenterologists, advanced practice providers, and colorectal surgeons from 5 continents. The majority (80%) use PROs in clinical practice, 65% frequently found value in routine use, and 50% frequently found PROs influenced management. Thirty-one different PROs for IBD were reportedly used. Barriers included not being familiar with PROs, not knowing how to incorporate PRO results into clinical practice, lack of electronic medical record integration, and time constraints. Most (91%) agreed it would be beneficial to have an accepted set of consistently used PROs. The majority (60%) thought that there should be some cultural differences in PROs used globally but that PROs for IBD should be consistent around the world. CONCLUSIONS: PROs are used frequently in clinical practice with wide variation in which are used and how they influence management. Education about PROs and how to use and interpret an accepted set of PROs would decrease barriers for use and allow for global harmonization.
Disciplines :
Gastroenterology & hepatology
Author, co-author :
Horrigan, Jamie M; Inflammatory Bowel Disease Center, Section of Gastroenterology and Hepatology,
Louis, Edouard ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gastroentérologie, hépatologie, onco. digestive
Spinelli, Antonino; Department of Biomedical Sciences, Humanitas University, IRCCS Humanitas Research
Travis, Simon; Kennedy Institute of Rheumatology, Translational Gastroenterology Unit, and
Moum, Bjorn; Department of Gastroenterology, Oslo University Hospital, Institute of Clinical
Salwen-Deremer, Jessica; Inflammatory Bowel Disease Center, Section of Gastroenterology and Hepatology, ; Department of Psychiatry, Section of Gastroenterology & Hepatology,
Halfvarson, Jonas; Department of Gastroenterology, Faculty of Medicine and Health, Örebro
Panaccione, Remo; Department of Medicine, University of Calgary, Calgary, Alberta, Canada. ; Department of Community Health Sciences, University of Calgary, Calgary, Alberta,
Dubinsky, Marla C; Department of Pediatrics, Susan and Leonard Feinstein IBD Center, Icahn School of
Munkholm, Pia; Department of Gastroenterology, North Zealand Hospital, University of Copenhagen,
Siegel, Corey A ; Inflammatory Bowel Disease Center, Section of Gastroenterology and Hepatology
Language :
English
Title :
The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel Disease.
Black N. Patient-reported outcome measures in skin cancer. Br J Dermatol. 2013;168(6):1151-1151.
Tran F, Schirmer JH, Ratjen I, et al. Patient reported outcomes in chronic inflammatory diseases: current state, limitations and perspectives. Front Immunol. 2021;12:614653.
Williet N, Sandborn WJ, Peyrin-Biroulet L. Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2014;12(8):1246- 1256.e6.
Sloan JA, Halyard MY, Frost MH, Dueck AC, Teschendorf B, Rothman ML; Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. The Mayo Clinic manuscript series relative to the discussion, dissemination, and operationalization of the Food and Drug Administration guidance on patient-reported outcomes. Value Health. 2007;10(Suppl 2):S59-S63.
Lohr KN, Zebrack BJ. Using patient-reported outcomes in clinical practice: challenges and opportunities. Qual Life Res. 2009;18(1):99-107.
Spiegel BM. Patient-reported outcomes in gastroenterology: clinical and research applications. J Neurogastroenterol Motil. 2013;19(2):137-148.
Kappelman MD, Palmer L, Boyle BM, Rubin DT. Quality of care in inflammatory bowel disease: A review and discussion. Inflamm Bowel Dis. 2009;16(1):125-133.
Tse CS, Van Citters AD, Ricci B, et al.; IBD Qorus. Identifying and predicting the goals and concerns prioritised by individuals with inflammatory bowel disease. J Crohns Colitis. 2022;16(3):379-388.
Wong D, Matini L, Kormilitzin A, et al. Patient reported outcomes: The ICHOM Standard Set for inflammatory bowel disease in real life practice helps quantify deficits in current care. J Crohns Colitis. 2022;16(12):1874-1881.
Farrell D, McCarthy G, Savage E. Self-reported symptom burden in individuals with inflammatory bowel disease. J Crohns Colitis. 2016;10(3):315-322.
de Rooy EC, Toner BB, Maunder RG, et al. Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol. 2001;96(6):1816-1821.
Borren NZ, van der Woude CJ, Ananthakrishnan AN. Fatigue in IBD: epidemiology, pathophysiology and management. Nat Rev Gastroenterol Hepatol. 2019;16(4):247-259.
Truyens M, De Ruyck E, Gonzales GB, Bos S, Laukens D, De Vos M. Prevalence of fatigue and unrecognized depression in patients with inflammatory bowel disease in remission under immunosuppressants and biologicals. J Clin Med. 2021;10(18):4107-41doi:10.3390/jcm10184107
Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of life in inflammatory bowel disease: A systematic review and meta-Analyses?Part I. Inflamm Bowel Dis. 2018;24(4):742-751.
Lonnfors S, Vermeire S, Greco M, Hommes D, Bell C, Avedano L. IBD and health-related quality of life?discovering the true impact. J Crohns Colitis. 2014;8(10):1281-1286.
de Jong MJ, Huibregtse R, Masclee AAM, Jonkers D, Pierik MJ. Patient-reported outcome measures for use in clinical trials and clinical practice in inflammatory bowel diseases: A systematic review. Clin Gastroenterol Hepatol. 2018;16(5):648-663.e3.
Jowett SL, Seal CJ, Barton JR, Welfare MR. The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis. Am J Gastroenterol. 2001;96(10):2921-2928.
Le Berre C, Bourreille A, Flamant M, et al. Protocol of a multicentric prospective cohort study for the VALIDation of the IBD-disk instrument for assessing disability in inflammatory bowel diseases: The VALIDate study. BMC Gastroenterol. 2020;20(1):110.
Abdovic S, Pavic AM, Milosevic M, Persic M, Senecic-Cala I, Kolacek S. Short health scale: A valid, reliable, and responsive measure of health-related quality of life in children with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(4):818-823.
Rencz F, Lakatos PL, Gulacsi L, et al. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease. Qual Life Res. 2019;28(1):141-152.
Gray WN, Denson LA, Baldassano RN, Hommel KA. Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17(7):1581-1586.
Kim AH, Roberts C, Feagan BG, et al. Developing a Standard Set of patient-centred outcomes for inflammatory bowel disease? an international, cross-disciplinary consensus. J Crohns Colitis. 2018;12(4):408-418.
Calvino-Suarez C, Ferreiro-Iglesias R, Baston-Rey I, Barreiro-de Acosta M. Role of quality of life as endpoint for inflammatory bowel disease treatment. Int J Environ Res Public Health. 2021;18(13). doi:10.3390/ijerph18137159
Bodger K, Ormerod C, Shackcloth D, Harrison M; IBD Control Collaborative. Development and validation of a rapid, generic measure of disease control from the patient's perspective: The IBDcontrol questionnaire. Gut. 2014;63(7):1092-1102.
El-Hussuna A, Rubio-Perez I, Millan M, et al.; OpenSourceResearch collaboration. Patient-reported outcome measures in colorectal surgery: construction of core measures using open-source research method. Surg Innov. 2021;28(5):560-566.
Helavirta I, Hyoty M, Oksanen P, Huhtala H, Haapamaki J, Aitola P. Health-related quality of life after restorative proctocolectomy: A cross-sectional study. Scand J Surg. 2018;107(4):315-321.
Losco A, Vigano C, Conte D, Cesana BM, Basilisco G. Assessing the activity of perianal Crohn's disease: comparison of clinical indices and computer-Assisted anal ultrasound. Inflamm Bowel Dis. 2009;15(5):742-749.
Yamamoto-Furusho JK, Bozada-Gutierrez KE, Sanchez-Rodriguez A, Bojalil-Romano F, Barreto-Zuniga R, Martinez-Benitez B. Validation of a novel integral disease index for evaluating the grade of activity in Mexican patients with ulcerative colitis: A prospective cohort study [Validacion de un nuevo indice integral de enfermedad para evaluar el grado de actividad en pacientes mexicanos con colitis ulcerosa: un estudio de cohorte prospectivo]. Rev Gastroenterol Mex (Engl Ed). 2019;84(3):317-325.
Marrie RA, Graff LA, Fisk JD, Patten SB, Bernstein CN. The relationship between symptoms of depression and anxiety and disease activity in IBD over time. Inflamm Bowel Dis. 2021;27(8):1285- 1293.
Vernon-Roberts A, Gearry RB, Day AS. Overview of self-management skills and associated assessment tools for children with inflammatory bowel disease. Gastrointest Disord. 2021;3(2):61-77.
Shen B, Achkar JP, Connor JT, et al. Modified pouchitis disease activity index: A simplified approach to the diagnosis of pouchitis. Dis Colon Rectum. 2003;46(6):748-753.
Oliver BJ, Kennedy AM, van Deen WK, et al. Development of balanced whole system value measures for inflammatory bowel disease care in the IBD Qorus collaborative using a modified Delphi process. Inflamm Bowel Dis. 2022;28(3):327-336.
Tinsley A, Macklin EA, Korzenik JR, Sands BE. Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2011;34(11-12):1328-1336.
Yarlas A, Maher SM, Bayliss MS, Lovley A, Cappelleri JC, DiBonaventura MD. Psychometric validation of the work productivity and activity impairment questionnaire in ulcerative colitis: results from a systematic literature review. J Patient Rep Outcomes. 2018;2(1):62.
de Jong ME, Taal E, Thomas PWA, et al. Cross-cultural translation and validation of the IBD-control questionnaire in The Netherlands: A patient-reported outcome measure in inflammatory bowel disease. Scand J Gastroenterol. 2021;56(2):155-161.
Armuzzi A, Tarallo M, Lucas J, et al. The association between disease activity and patient-reported outcomes in patients with moderate-To-severe ulcerative colitis in the United States and Europe. BMC Gastroenterol. 2020;20(1):18.
Brenner EJ, Long MD, Mann CM, et al. Responsiveness of the Patient-reported Outcomes Measurement Information System (PROMIS) pediatric measures to changes in disease status and quality of life among children and adolescents with Crohn's disease. Inflamm Bowel Dis. 2021;27(3):344-351.
Fletcher J, Cooper SC, Swift A. Patient-reported outcomes in inflammatory bowel disease: A measurement of effect in research and clinical care. Gastroenterology Insights. 2021;12(2):225-237
